Researchers at Boston University School of Medicine have discovered a new approach to paediatric asthma care by blocking certain neurogenic changes that occur in the lungs in childhood. With this approach, patients may also be able to avoid asthma and allergic responses into adulthood. The research, presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting-2022, focused on several divisions of the nervous system, including sensory and sympathetic nerves, and found the data on cholinergic nerves most interesting. The team said that the nerve property functions as the “first responder” and thus, can be used to diagnose asthma in infants. With the current study, the researchers hope to change the general perspective on how nerves influence asthma and allergy responses in paediatric patients, and said that with the new development of neutralising antibodies, paediatric patients can be administered treatments that are safer than general anti-inflammatory drugs.